BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/23/2020 7:15:20 PM | Browse: 525 | Download: 516
Publication Name World Journal of Gastroenterology
Manuscript ID 51778
Country China
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Prognostic value of preoperative weight loss adjusted body mass index on survival after esophagectomy for esophageal squamous cell carcinoma
Manuscript Source Invited Manuscript
All Author List Han-Lu Zhang, Yu-Shang Yang, Jia-Nan Duan, Qi-Xin Shang, Song-Lin He, Yi-Min Gu, Wei-Peng Hu, Wen-Ping Wang, Yang Hu, Yun Wang, Yong Yuan and Long-Qi Chen
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 81970481
Sichuan Science and Technology Program 2018HH0150
Chengdu Science and Technology Bureau 2017GH00072
Corresponding Author Yong Yuan, MD, PhD, Associate Professor, Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, Sichuan Province, China. dy818@sina.com
Key Words Esophageal neoplasms; Body mass index; Body weight change; Survival; Surgery; Nutrition status
Core Tip The aim of this study was to explore the impact of preoperative weight loss (PWL) adjusted body mass index (BMI) on overall survival for patients undergoing surgery for esophageal squamous cell carcinoma. Patients with BMI ≥ 20.0 kg/m2 and PWL < 8.8% were classified in Group 1. Patients with BMI < 20.0 kg/m2 and PWL < 8.8% were classified in Group 2. Patients with PWL ≥ 8.8% were classified in Group 3. Patients in the three groups were associated with significantly different overall survival. This result indicates that PWL-adjusted BMI has prognostic value for patients undergoing surgery for esophageal squamous cell carcinoma.
Citation Zhang HL, Yang YS, Duan JN, He SL, Gu YM, Hu WP, Wang WP, Hu Y, Wang Y, Yuan Y, Chen LQ. Prognostic value of preoperative weight loss adjusted body mass index on survival after esophagectomy for esophageal squamous cell carcinoma. World J Gastroenterol 2020; 26(8): 839-849
Received
2019-10-09 14:32
Peer-Review Started
2019-10-09 14:32
To Make the First Decision
Return for Revision
2019-12-23 19:38
Revised
2020-01-13 16:38
Second Decision
2020-01-22 04:16
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-01-23 19:15
Articles in Press
2020-01-23 19:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
2020-02-13 06:49
Typeset the Manuscript
2020-02-26 08:00
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com